Comparison of different glucocorticoid regimens in the management of classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Background: There are recommendations regarding the total dose of hydrocortisone to be administered in the treatment of classical congenital adrenal hyperplasia (CAH) to achieve the twin objectives of glucocorticoid replacement and control of hyperandrogenism. However, there is evidence gap regardin...
Main Authors: | T P Ajish, V P Praveen, B Nisha, Harish Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2014;volume=18;issue=6;spage=815;epage=820;aulast=Ajish |
Similar Items
-
Health-related quality of life in children with congenital adrenal hyperplasia
by: Alyssa Halper, et al.
Published: (2017-10-01) -
Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency
by: Kathrin R Frey, et al.
Published: (2018-06-01) -
The outcome of height in a cohort of children with congenital adrenal hyperplasia: a preliminary report from Sri Lanka
by: A. S. Athapathu, et al.
Published: (2016-08-01) -
Prednisolone has the same cardiovascular risk profile as hydrocortisone in glucocorticoid replacement
by: David J F Smith, et al.
Published: (2017-10-01) -
Adrenal Tumor Mimicking Non-Classic Congenital Adrenal Hyperplasia
by: Wen-Hsuan Tsai, et al.
Published: (2020-09-01)